SOUTH EASTON, Mass., Dec. 11 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI" or the "Company") and Omni International ("Omni") today announced that they have entered into a strategic marketing, distribution, and technology co-development Agreement. Under the terms of the Agreement, the companies will: (1) share market data, customer leads, technology assessments, and competitive information; (2) co-promote certain products at industry trade shows beginning in 2009; (3) license Omni to sell PBI's recently released, patent-pending PCT Shredder to laboratories worldwide; and (4) co-develop new instrumentation and consumables that combine the homogenization capabilities of Omni with the extraction capabilities of PBI, in an effort to provide research scientists with a targeted approach to better solve certain sample preparation issues.
Mr. Karl Jahn, President of Omni, said: "PBI is the leading company in the world in providing laboratory scale, ultra-high pressure cycling instrumentation for biomolecule extraction. Omni has been one of the world's leading suppliers of laboratory scale homogenizers for decades. Our two companies' technologies are extremely complementary and synergistic. To that end, we believe that combining the advantages of both technologies could offer the customer a range of solutions to ensure efficient extraction for many sample types, particularly those that continue to pose challenges in sample preparation. We are therefore pleased to have PBI, with its wealth of experience, novel technology, and IP, as a strategic business partner, and we look forward to working with them in developing an entirely new concept in solution-based products for the large sample preparation market."
Mr. Jahn continued: "We also look forward to marketing and selling the PCT Shredder in early 2009. Thi
|SOURCE Pressure BioSciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved